Emerest

Digestive System

Emerest

Ondansetron 4 mg /2 ml - 5 Ampoules 2 ml

Ondansetron 8 mg - 10 fast melt tablets

Emerest 4mg-2ml Amp

Therapeutic Indications:

Adults:

Emerest is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy

and radiotherapy, and for the prevention and treatment of post-operative nausea and vomiting (PONV).

Pedialric Popula1ion:

Emerest is indicated for the management of chemotherapy-induced nausea and vomiting (CINV) in

children aged < = 6 months, and for the prevention and treatment of PONV in children aged< = 1 month.

Posology and method of administration :

For intravenous injection or for intravenous infusion after dilution.

Prescribers intending to use Emerest in the prevention of delayed nausea and vomiting associated with

chemotherapy or radiotherapy in adults, adolescents or children should take into consideration current

practice and appropriate guidelines.

Emerest 8mg Fast Melt Tab

Therapeutic Indications:

Adulis:

Emerest is indicatcd for the management of nausea and vomiting induced by cytotoxic

chemotherapy andrad otherapy.

Emerest is indicated for the prevention of post--operative nausea and vomiting (PONY).

For tratmenl of es1ablished PONY, administration by injection is recommended.

Emerest is indicated for the management of chemotherapy-induced nausea and vomiting (CINV) in children aged > = 6months

No studies have been conducted on the use of orally administered ondansetron in the

prevention and treatment of PONY in children aged =<1 month, administra1ion by IV injection is recommended for this purpose.